These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2921600)

  • 41. [Diagnostic significance of IgM class-specific antibodies in influenza].
    Ivanova LA; Ketiladze ES; Krylov VF; Poliakova TG; Grishchenko SV
    Vopr Virusol; 1986; 31(1):116-8. PubMed ID: 3515763
    [No Abstract]   [Full Text] [Related]  

  • 42. Antiviral antibodies in the sera of homosexual men: correlation with their lifestyle and drug usage.
    Nerurkar LS; Biggar RJ; Goedert JJ; Wallen W; Becker P; West F; Tzan N; Traub R; Lee YJ; Botelar W
    J Med Virol; 1987 Feb; 21(2):123-35. PubMed ID: 3029318
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of zanamivir treatment on the early immune response to influenza vaccination.
    Cox RJ; Mykkeltvedt E; Sjursen H; Haaheim LR
    Vaccine; 2001 Sep; 19(32):4743-9. PubMed ID: 11535325
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adjuvant activity of the heat-labile enterotoxin from enterotoxigenic Escherichia coli for oral administration of inactivated influenza virus vaccine.
    Katz JM; Lu X; Young SA; Galphin JC
    J Infect Dis; 1997 Feb; 175(2):352-63. PubMed ID: 9203656
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antibody responses of horses to equine influenza viruses during a postepizootic period in Japan.
    Goto H; Shimizu K; Taya Y; Noda H; Tokunaga T
    Can J Comp Med; 1982 Jan; 46(1):27-32. PubMed ID: 7074415
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quality and quantity of the humoral immune response in healthy elderly and young subjects after annually repeated influenza vaccination.
    de Bruijn IA; Remarque EJ; Jol-van der Zijde CM; van Tol MJ; Westendorp RG; Knook DL
    J Infect Dis; 1999 Jan; 179(1):31-6. PubMed ID: 9841819
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Efficacy of influenza vaccine among geriatric inpatients: effect of previous vaccination and antibody induction by single and twice injections].
    Ikematsu H; Nabeshima A; Yamaji K; Chong Y; Li W; Hayashi J; Goto S; Oka T; Shirai T; Kashiwagi S
    Kansenshogaku Zasshi; 1999 Oct; 73(10):1042-7. PubMed ID: 10565120
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative analysis of influenza A(H3N2) virus hemagglutinin specific IgG subclass and IgA responses in children and adults after influenza vaccination.
    Manenti A; Tete SM; Mohn KG; Jul-Larsen Å; Gianchecchi E; Montomoli E; Brokstad KA; Cox RJ
    Vaccine; 2017 Jan; 35(1):191-198. PubMed ID: 27789145
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection.
    Ohmit SE; Petrie JG; Cross RT; Johnson E; Monto AS
    J Infect Dis; 2011 Dec; 204(12):1879-85. PubMed ID: 21998477
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunogenicity and safety of zoster vaccine live administered with quadrivalent influenza virus vaccine.
    Levin MJ; Buchwald UK; Gardner J; Martin J; Stek JE; Brown E; Popmihajlov Z
    Vaccine; 2018 Jan; 36(1):179-185. PubMed ID: 28830693
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An α-GalCer analogue with branched acyl chain enhances protective immune responses in a nasal influenza vaccine.
    Lee YS; Lee KA; Lee JY; Kang MH; Song YC; Baek DJ; Kim S; Kang CY
    Vaccine; 2011 Jan; 29(3):417-25. PubMed ID: 21087689
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Determination of hemagglutination inhibiting antibodies against influenza virus A/Port Chalmers/1/73 in samples from the Roman population (1962-1974). Relation of antibody titers to those obtained against previous influenza A strains].
    Castagnari L; Delia S; Russo V; Sebastiani A
    Ann Sclavo; 1975; 17(2):129-39. PubMed ID: 1227406
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Live, attenuated influenza A/England/42/72 (H3N2) virus vaccine: a field trial.
    Rubin RJ; Noble GR; Corey L; Brown WJ; Brandling-Bennett D; Kaye HS; Coleman MT; Gregg MB; Dowdle WR
    J Infect Dis; 1976 Jun; 133(6):613-20. PubMed ID: 778302
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro production of anti-influenza virus antibody after simultaneous administration of H3N2 and H1N1 cold-adapted vaccines in seronegative children.
    Edwards KM; Snyder P; Thompson JM; Johnson PR; Wright PF
    Vaccine; 1986 Mar; 4(1):50-4. PubMed ID: 3962451
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immune responses of mice to influenza subunit vaccine in combination with CIA07 as an adjuvant.
    Park SA; Song ES; Cho YJ; Ahn BY; Ha SH; Seong BL; Lee KH; Lee NG
    Microbiol Immunol; 2007; 51(11):1099-107. PubMed ID: 18037787
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of rimantadine on the immune response to influenza A infections.
    Clover RD; Waner JL; Becker L; Davis A
    J Med Virol; 1991 May; 34(1):68-73. PubMed ID: 1885945
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oral LY217896 for prevention of experimental influenza A virus infection and illness in humans.
    Hayden FG; Tunkel AR; Treanor JJ; Betts RF; Allerheiligen S; Harris J
    Antimicrob Agents Chemother; 1994 May; 38(5):1178-81. PubMed ID: 8067760
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Method for determining the equilibrium constant and the concentration of influenza virus IgG antihaemagglutinin antibody molecules by use of EIA titres determined with and without guanidine hydrochloride.
    Drescher J; Verhagen W
    J Virol Methods; 1994 May; 47(3):307-19. PubMed ID: 8071419
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antibody response in rabbits to antigenic stimulation during amantadine treatment.
    Muldoon RL; Jackson GG
    Proc Soc Exp Biol Med; 1967 Oct; 126(1):26-30. PubMed ID: 6066175
    [No Abstract]   [Full Text] [Related]  

  • 60. A Dose-finding Study of a Wild-type Influenza A(H3N2) Virus in a Healthy Volunteer Human Challenge Model.
    Han A; Czajkowski LM; Donaldson A; Baus HA; Reed SM; Athota RS; Bristol T; Rosas LA; Cervantes-Medina A; Taubenberger JK; Memoli MJ
    Clin Infect Dis; 2019 Nov; 69(12):2082-2090. PubMed ID: 30770534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.